Revises certain requirements for prescription of Schedule II controlled dangerous substances via telemedicine and telehealth without in-person examination or review.*

{"id": "ocd-bill/6d8a3d8d-cf3c-4037-87bd-29f0fb8059b9", "session": "222", "jurisdiction": {"id": "ocd-jurisdiction/country:us/state:nj/government", "name": "New Jersey", "classification": "state"}, "from_organization": {"id": "ocd-organization/68d34c4f-e59d-42a2-bcfe-fbf7f8cc8f15", "name": "Assembly", "classification": "lower"}, "identifier": "A 4852", "title": "Revises certain requirements for prescription of Schedule II controlled dangerous substances via telemedicine and telehealth without in-person examination or review.*", "classification": ["bill"], "subject": [], "extras": {}, "created_at": "2026-03-24T11:09:13.146924+00:00", "updated_at": "2026-07-09T19:38:03.023591+00:00", "openstates_url": "https://openstates.org/nj/bills/222/A4852/", "first_action_date": "2026-05-04T04:00:00+00:00", "latest_action_date": "2026-07-08T04:00:00+00:00", "latest_action_description": "Approved P.L.2026, c.40.", "latest_passage_date": "2026-06-30T04:00:00+00:00"}